PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CI vs. CTAS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CICTAS
YTD Return14.52%12.09%
1Y Return42.68%48.66%
3Y Return (Ann)11.53%25.60%
5Y Return (Ann)18.80%25.88%
10Y Return (Ann)15.77%29.10%
Sharpe Ratio1.422.64
Daily Std Dev29.12%18.44%
Max Drawdown-84.34%-65.35%
Current Drawdown-6.20%-1.89%

Fundamentals


CICTAS
Market Cap$97.01B$68.39B
EPS$17.39$14.49
PE Ratio19.6446.52
PEG Ratio0.893.79
Revenue (TTM)$195.19B$9.41B
Gross Profit (TTM)$22.98B$3.63B
EBITDA (TTM)$10.72B$2.30B

Correlation

-0.50.00.51.00.3

The correlation between CI and CTAS is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CI vs. CTAS - Performance Comparison

In the year-to-date period, CI achieves a 14.52% return, which is significantly higher than CTAS's 12.09% return. Over the past 10 years, CI has underperformed CTAS with an annualized return of 15.77%, while CTAS has yielded a comparatively higher 29.10% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


10,000.00%20,000.00%30,000.00%40,000.00%50,000.00%60,000.00%70,000.00%December2024FebruaryMarchAprilMay
17,418.21%
66,445.56%
CI
CTAS

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Cigna Corporation

Cintas Corporation

Risk-Adjusted Performance

CI vs. CTAS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and Cintas Corporation (CTAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CI
Sharpe ratio
The chart of Sharpe ratio for CI, currently valued at 1.42, compared to the broader market-2.00-1.000.001.002.003.004.001.42
Sortino ratio
The chart of Sortino ratio for CI, currently valued at 2.26, compared to the broader market-4.00-2.000.002.004.006.002.26
Omega ratio
The chart of Omega ratio for CI, currently valued at 1.34, compared to the broader market0.501.001.501.34
Calmar ratio
The chart of Calmar ratio for CI, currently valued at 1.47, compared to the broader market0.002.004.006.001.47
Martin ratio
The chart of Martin ratio for CI, currently valued at 7.93, compared to the broader market-10.000.0010.0020.0030.007.93
CTAS
Sharpe ratio
The chart of Sharpe ratio for CTAS, currently valued at 2.64, compared to the broader market-2.00-1.000.001.002.003.004.002.64
Sortino ratio
The chart of Sortino ratio for CTAS, currently valued at 3.90, compared to the broader market-4.00-2.000.002.004.006.003.90
Omega ratio
The chart of Omega ratio for CTAS, currently valued at 1.53, compared to the broader market0.501.001.501.53
Calmar ratio
The chart of Calmar ratio for CTAS, currently valued at 5.72, compared to the broader market0.002.004.006.005.72
Martin ratio
The chart of Martin ratio for CTAS, currently valued at 17.89, compared to the broader market-10.000.0010.0020.0030.0017.89

CI vs. CTAS - Sharpe Ratio Comparison

The current CI Sharpe Ratio is 1.42, which is lower than the CTAS Sharpe Ratio of 2.64. The chart below compares the 12-month rolling Sharpe Ratio of CI and CTAS.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
1.42
2.64
CI
CTAS

Dividends

CI vs. CTAS - Dividend Comparison

CI's dividend yield for the trailing twelve months is around 1.49%, more than CTAS's 0.77% yield.


TTM20232022202120202019201820172016201520142013
CI
Cigna Corporation
1.49%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%0.04%0.05%
CTAS
Cintas Corporation
0.77%0.83%0.93%0.77%0.20%0.95%1.22%1.04%1.15%1.15%2.17%1.28%

Drawdowns

CI vs. CTAS - Drawdown Comparison

The maximum CI drawdown since its inception was -84.34%, which is greater than CTAS's maximum drawdown of -65.35%. Use the drawdown chart below to compare losses from any high point for CI and CTAS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-6.20%
-1.89%
CI
CTAS

Volatility

CI vs. CTAS - Volatility Comparison

Cigna Corporation (CI) has a higher volatility of 4.58% compared to Cintas Corporation (CTAS) at 3.26%. This indicates that CI's price experiences larger fluctuations and is considered to be riskier than CTAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
4.58%
3.26%
CI
CTAS

Financials

CI vs. CTAS - Financials Comparison

This section allows you to compare key financial metrics between Cigna Corporation and Cintas Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items